複雑性尿路感染症に対するCefbuperazone(CBPZ)の臨床使用経験

HANDLE オープンアクセス

書誌事項

タイトル別名
  • Clinical experience with cefbuperazone in complicated urinary tract infection

この論文をさがす

抄録

Cefbuperazone (CBPZ) was administered to inpatients with complicated urinary tract infections (UTI) at our department. Clinical efficacy and safety were evaluated in 22 chronic cases by the criteria for evaluation of clinical of antimicrobial agents on urinary tract infection. Overall clinical efficacy was excellent in 8 cases, moderate in 9 cases and poor in 5 cases with an effectiveness rate of 77%. Twenty-four of the 34 strains isolated from the patients were eradicated and eradication rate was 71%. Neither subjective nor objective adverse reactions were observed. Abnormal changes in laboratory tests were found in 9 patients, but were probably not related to CBPZ administration. Judging from these results, CBPZ is considered to be an effective and safe antibacterial for the treatment of complicated UTI.

収録刊行物

  • 泌尿器科紀要

    泌尿器科紀要 33 (5), 786-793, 1987-05

    泌尿器科紀要刊行会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ